Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
about
Review on molecular and therapeutic potential of thymoquinone in cancerPancreatic cancer: pathogenesis, prevention and treatmentIs metastatic pancreatic cancer an untargetable malignancy?Oxidative stress and cytokines in the pathogenesis of pancreatic cancerThe complexities of epidemiology and prevention of gastrointestinal cancersActivated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathwaysSynergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expressionGenistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrestGalangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway.Improving In Vivo Efficacy of Bioactive Molecules: An Overview of Potentially Antitumor Phytochemicals and Currently Available Lipid-Based Delivery Systems.Biological approaches to therapy of pancreatic cancer.Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets.Thiol-ene hydrogels as desmoplasia-mimetic matrices for modeling pancreatic cancer cell growth, invasion, and drug resistance.Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesisEffects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer CellsThe molecular targets for the diagnosis and treatment of pancreatic cancer.Genistein potentiates the antitumor effect of 5-Fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells.Genistein abrogates G2 arrest induced by curcumin in p53 deficient T47D cellsRestoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo.The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.N-(4-Hydroxyphenyl) Retinamide Potentiated Anti-tumor Efficacy of Genistein in Human Ewing's Sarcoma Xenografts.Phytochemicals in cancer prevention and therapy: truth or dare?Effects of Combined Soy Isoflavone Extract and Docetaxel Treatment on Murine 4T1 Breast Tumor Model.Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cellsEnhanced solubility and targeted delivery of curcumin by lipopeptide micelles.Enhanced antitumor efficacy of gemcitabine by evodiamine on pancreatic cancer via regulating PI3K/Akt pathway.Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatmentCurrent knowledge on pancreatic cancer.Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization.Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cellsOncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesisSelective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in miceTargeting signal transduction in pancreatic cancer treatment.Gambogic acid enhances proteasome inhibitor-induced anticancer activity.Synergistic effects of multiple natural products in pancreatic cancer cellsAntioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?Multi-targeted therapy of cancer by genisteinDietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression.Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2
P2860
Q24563172-BE0AEE16-93D3-4B4A-A8D6-C8FBC9B8023CQ24670990-1E6C1C0A-0DE6-489A-893F-B03F3B75FFBCQ26753849-2419F2DD-D447-42C0-B403-E80933AD88D2Q26824025-1A2098EE-9A4E-407B-92AD-A67CAD8EFECBQ26865429-8A439AE7-C0D5-422F-9464-8817A2A6C418Q28478427-F48BC231-8C74-4DAF-B1E6-D922B062EEE9Q28542871-8F7170B0-856E-4001-9675-09888D3BA9D5Q33241207-EF4F0641-EC74-41B7-8849-64E7745FF5A6Q33633196-1365B203-7DFA-40A2-A75E-BE49D92D3634Q33710442-01616122-87AB-424C-9F06-BADF88D6BA36Q33899938-9CBBB8EC-2F04-4DEA-A9D0-C4BB33B9E17FQ34069637-90AA5586-3D44-4E14-A4F1-F13F89ECDA43Q34183997-3334731D-0E1F-4474-8C10-16648D10FC5EQ34372558-442D0587-B39E-4F3F-941E-709B1D533D81Q34487091-9F84A541-3035-433E-A936-688533564DC1Q34494019-D870D340-4902-4832-9726-9E2585545029Q34557397-B5DC07A1-9111-4751-A38B-0D084761F4CAQ34564108-C987561F-7B4F-4658-932A-AE5D2B02D872Q34573492-38DF6C08-A979-432F-9E44-85B25DABB6CFQ34690409-044AA92A-9C5C-4A2E-81AC-B7F942D37589Q35149953-957791F6-EE63-4C97-A338-B1EB7B03634CQ35155749-4C797EFD-2FF7-4AEB-8A87-34F0D2816EE0Q35307027-F62E7C2B-CFCA-4990-862D-F35203D30FC6Q35486194-A107796E-C7C3-4F70-8CB5-08832FDBEDCFQ35549235-1A7C3736-AD8E-4190-8D19-53A5DD8CBFCEQ35578720-6A559A7E-2B64-4CA0-B3E1-79CC19700D68Q35719620-3A7F41C9-35AF-4FAA-B57D-A2276DD7887EQ35722741-11FA16A0-5C80-42E9-9F2B-FAD529C273F8Q35971808-A936C3E1-6770-4758-8D34-4542F4B2DE02Q36037180-95613AC2-9662-44A1-9FBF-FA3F647739C9Q36078490-C9AA89C8-67EF-4648-A21C-0140B486F6FBQ36516948-CD7D32F7-F31B-4D77-A75E-7C86694FCA6CQ36675242-E59126BF-5D11-4E57-BE42-FAC67C384340Q36804444-B4BDEFAE-6E4F-420F-AF29-EEBDED2508C4Q36869779-04C03AAC-B03C-49A0-947E-04D55FF38266Q36876691-8D027BAD-9F2E-47EB-870B-463DBB7727B1Q36945706-0F5039D6-8CFF-44D4-A21B-3ACC79243F81Q36955543-338E6A67-1C40-4D2D-8164-6FBB9829F595Q36961488-F4E5658E-FFD6-4D5D-879C-40758A2C17E6Q37012408-EC2C3792-D328-4F3A-8CB1-BAF88C9B2C1D
P2860
Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Molecular evidence for increas ...... ic model of pancreatic cancer.
@en
type
label
Molecular evidence for increas ...... ic model of pancreatic cancer.
@en
prefLabel
Molecular evidence for increas ...... ic model of pancreatic cancer.
@en
P2093
P1433
P1476
Molecular evidence for increas ...... ic model of pancreatic cancer.
@en
P2093
Fazlul H Sarkar
James Abbruzzese
Mohammad Bhuiyan
Paul J Chiao
Philip A Philip
Sanjeev Banerjee
Shadan Ali
Yuxiang Zhang
Zhiwei Wang
P304
P356
10.1158/0008-5472.CAN-05-1330
P407
P577
2005-10-01T00:00:00Z